Detection and follow-up of Wegener's prostatitis by transrectal ultrasound.
I B
IB
Menown
W R
WR
McKane
J A
JA
Kennedy
I M
IM
Kelly
B A
BA
Maclennan
B G
BG
Best
M Y
MY
Walsh
D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D014890:Granulomatosis with Polyangiitis / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D011467:Prostate / Q000473:pathology; D011472:Prostatitis / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000209:etiology; D014463:Ultrasonography; D016055:Urinary Retention / Q000209:etiology
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D018501:Antirheumatic Agents; D002939:Ciprofloxacin; D003520:Cyclophosphamide; D011239:Prednisolone